All the latest news and stories about Alzheimer's disease, dementia, and the brain.

What news are you looking for?

Alzheimer Society of Canada position on aducanumab decision

Canada
June 9, 2022

The Alzheimer Society of Canada has been made aware of the decision by Biogen Canada Inc. to withdraw its submission of aducanumab from regulatory review by Health Canada as a treatment for people living with early stages of Alzheimer’s disease.

Alzheimer Society of Canada wordmark and identifier.